NCT00192452View on ClinicalTrials.gov

Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

December 31, 2001

Conditions
Psoriasis
Interventions
DRUG

MEDI-507

Trial Locations (3)

27157

Wake Forest University School of Medicine, Winston-Salem

85044

MDS Pharma Services (US) Inc., Phoenix

98403

Northwest Kinetics, Tacoma

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY